CTOR
Citius Oncology, Inc.
CTOR • XNAS
Citius Oncology, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Leonard L. Mazur, with a market cap of $45.2M.
CEOLeonard L. Mazur
Market Cap$45.2M
PHARMACEUTICAL PREPARATIONS
Next Earnings
Upcoming earnings announcement for Citius Oncology, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.01
Revenue Estimate
$7.0M
Earnings History
Past 7 earnings reports for Citius Oncology, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Q1 2026 | -$0.06Est: -$0.04 | -50.0% | $3.9MEst: $4.4M | -9.8% |  10-Q |
| Dec 23, 2025 | Q4 2025 | -$0.06Est: -$0.06 | 0.0% | - | — | 10-K |
| Aug 12, 2025 | Q3 2025 | -$0.08 | — | - | — | 10-Q |
| May 14, 2025 | Q2 2025 | -$0.11 | — | - | — | 10-Q |
| Feb 14, 2025 | Q1 2025 | -$0.09 | — | - | — | 10-Q |
| Dec 27, 2024 | Q4 2024 | -$0.14 | — | - | — | 10-K/A |
| Aug 12, 2024 | Q3 2024 | -$0.06 | — | - | — | 10-Q |